Amino acid replacement: G2054R.
G15054232A
G2054R | hiw-PA; G2054R | hiw-PB
G2054R
The site of the nucleotide substitution in the mutant was inferred by FlyBase based on the reported amino acid change.
Mutant larvae show a modest but significant increase in the number of boutons at the neuromuscular junction compared to wild type
Homozygous hiwND51 mutants exhibit a statistically significant increase in bouton number for muscle 4 synapses compared to controls.
Mutant larvae show mild synaptic terminal overgrowth at the neuromuscular junction.
hiwND51 has abnormal neuroanatomy | larval stage phenotype, enhanceable by SkpAGD65
hiwND51 has abnormal neuroanatomy | third instar larval stage phenotype, enhanceable by Fsnf06595
hiwND51 has NMJ bouton | larval stage phenotype, enhanceable by SkpAGD65
hiwND51 has embryonic/larval neuromuscular junction | larval stage phenotype, enhanceable by SkpAGD65
hiwND51 has embryonic/larval neuromuscular junction phenotype, enhanceable by Rae1[+]/Rae1EX28
hiwND51 has NMJ bouton phenotype, enhanceable by Rae1[+]/Rae1EX28
hiwND51 has embryonic/larval neuromuscular junction phenotype, enhanceable by Fsnf06595
hiwND51 has NMJ bouton | increased number phenotype, enhanceable by Fsnf06595
The synaptic overgrowth phenotype (increase in bouton number) seen at the neuromuscular junction in hiwND51 mutants is dramatically enhanced in hiwND51 SkpAGD65 double mutants.
hiwND51 SkpAGD65 double mutant larvae show a decrease in excitatory junctional potential amplitude and in quantal content compared to wild type.